October 19, 2017 7:57 AM ET


Company Overview of Prevacus, Inc.

Company Overview

Prevacus, Inc., a drug development company, is engaged in the prevention and treatment of mild traumatic brain injury or concussion. It provides Prevasol nasal spray, which is used to reduce edema, inflammation, and oxidative stress. The company was founded in 2012 and is based in Tallahassee, Florida.

2035 East Paul Dirac Drive

Suite 106

Innovation Park

Tallahassee, FL 32310

United States

Founded in 2012



Key Executives for Prevacus, Inc.

Founder, Chief Executive Officer and Lead Scientific Consultant
Chief Scientific Officer
Compensation as of Fiscal Year 2017.

Prevacus, Inc. Key Developments

Prevacus Inc. Announces the Addition of Randy Travis to Advisory Board

Prevacus, Inc. announced a partnership with Randy Travis and The Randy Travis Foundation. Randy and his Foundation will join others at Prevacus including Brett Favre, Jay Saldi, Roger Staubach, Leigh Steinberg, James ‘Bus’ Cook, Abby Wambach, Dale Jarrett, Steve Mariucci, Eddie DeBartolo Jr., Matt Hasselbeck, Warren Moon and Kerri Walsh-Jennings.

Prevacus, Inc. Announces the Addition of Key Individuals to its Sports Advisory Board

Prevacus, Inc. announced the addition of Steve Mariucci, Eddie DeBartolo Jr., Matt Hasselbeck and Warren Moon to its sports advisory board. Steve Mooch Mariucci is the former Head Coach for the NFL with both the San Francisco 49ers and Detroit Lions. He was also Brett Favre’s Quarterback coach when he arrived in Green Bay. Mooch is on the NFL Safety and Rules Advisory Board. Mr. DeBartolo is the former owner of the San Francisco 49 ers where he won 5 Super Bowls. He has had immense success in Real Estate and as a Philanthropist. Matt is a former NFL Quarterback with most of his playing days spent with the Seattle Seahawks. He is currently a member of the NFL ESPN analyst team. Matt is currently an executive member of the NFLPA union and works tirelessly on behalf of the players. Warren Moon is a Hall of Fame NFL Quarterback and is currently a commentator for the Seahawks radio network. Mr. Moon co-founded Sports 1 Marketing in 2010.

Prevacus, Inc. to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

Prevacus, Inc. announced plans to initiate Phase 1 clinical studies of a novel treatment for concussion in humans. The company expects to initiate its Phase 1 trial during the first half of 2017. These clinical studies will examine the potential of Prevacus' proprietary compound PRV-002 for concussion treatment in humans. In pre-clinical animal studies, the compound performed positively in all measured areas, including memory score, sensory-motor function, anxiety, cerebral edema, cell death and cellular regeneration. PRV-002 is administered nasally providing for a 4-fold higher exposure to the injured brain while simultaneously reducing potential adverse effects on other regions of the body. Furthermore, the compound appears to be over 380-fold safe in toxicology and safety studies in three separate species.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prevacus, Inc., please visit www.prevacus.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.